Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Capital Expenditures (2020 - 2023)

Historic Capital Expenditures for Terns Pharmaceuticals (TERN) over the last 4 years, with Q4 2023 value amounting to $44000.0.

  • Terns Pharmaceuticals' Capital Expenditures rose 2941.18% to $44000.0 in Q4 2023 from the same period last year, while for Dec 2023 it was $52000.0, marking a year-over-year decrease of 8109.09%. This contributed to the annual value of $42000.0 for FY2024, which is 1923.08% down from last year.
  • According to the latest figures from Q4 2023, Terns Pharmaceuticals' Capital Expenditures is $44000.0, which was up 2941.18% from $8000.0 recorded in Q3 2023.
  • Terns Pharmaceuticals' Capital Expenditures' 5-year high stood at $430000.0 during Q1 2020, with a 5-year trough of -$8000.0 in Q3 2022.
  • Over the past 4 years, Terns Pharmaceuticals' median Capital Expenditures value was $43000.0 (recorded in 2021), while the average stood at $89357.1.
  • In the last 5 years, Terns Pharmaceuticals' Capital Expenditures soared by 138000.0% in 2021 and then tumbled by 11081.08% in 2022.
  • Terns Pharmaceuticals' Capital Expenditures (Quarter) stood at $47000.0 in 2020, then surged by 325.53% to $200000.0 in 2021, then crashed by 83.0% to $34000.0 in 2022, then rose by 29.41% to $44000.0 in 2023.
  • Its Capital Expenditures stands at $44000.0 for Q4 2023, versus $8000.0 for Q3 2023 and $34000.0 for Q4 2022.